Proton pump inhibitor
Pantoprazole in Japan: prescription, brands, pricing
This page summarises the situation of Pantoprazole in Japan under PMDA (Pharmaceuticals and Medical Devices Agency): prescription status, available brands and generics, pharmacy dispensing, and online options in JPY. Pantoprazole belongs to the Proton pump inhibitor class.
- Regulator
- PMDA (Pharmaceuticals and Medical Devices Agency)
- Currency
- JPY
About Pantoprazole
Pantoprazole is approved in adults and children for the treatment of gastro-oesophageal reflux disease, including erosive oesophagitis healing and maintenance, peptic ulcer disease, prevention of NSAID-induced ulcers, Zollinger-Ellison synd… Japan classifies medicines into prescription drugs (医療用医薬品) and OTC drugs (一般用医薬品), the latter further divided into pharmacist-only (第1類) and self-service classes. The Ministry of Health, Labour and Welfare (MHLW) sets the regulatory framework; PMDA reviews safety and efficacy.
Mechanism and action
Pantoprazole is a substituted benzimidazole prodrug activated in the acidic environment of the gastric parietal cell, where it irreversibly inhibits the H+/K+-ATPase enzyme — the proton pump responsible for the final step in gastric acid se…
Brands and generics in Japan
In Japan, Pantoprazole is typically dispensed as one internationally recognised brand along with their corresponding authorised generics. Japanese pharmacies (薬局) and drugstores (ドラッグストア) such as Matsumoto Kiyoshi and Welcia are widespread. Prescription dispensing pharmacies (調剤薬局) are usually located near hospitals and clinics; pharmacist counselling at dispensing is mandated by the Pharmaceutical Affairs Law. Brand-to-generic substitution is decided by the pharmacist under local PMDA (Pharmaceuticals and Medical Devices Agency) equivalence rules, and the price difference in JPY is usually substantial.
Online and tele-prescribing access
Japan permits online sale of most OTC medicines under the 2014 amendments to the Pharmaceutical Affairs Law, with class-based restrictions. Online prescription dispensing is allowed via licensed pharmacies after a face-to-face or telemedicine consultation; personal importation of prescription medication is restricted to limited quantities for personal use. For Pantoprazole specifically, the legal online options in Japan depend on its Rx-or-OTC classification under PMDA (Pharmaceuticals and Medical Devices Agency).
Frequently asked questions
Is Pantoprazole available in Japan? ▾
Yes — Pantoprazole and its brands are available in Japan through pharmacies authorised by PMDA (Pharmaceuticals and Medical Devices Agency), in various strengths depending on the commercial product. Authorised generics offer a lower-cost alternative with the same active substance.
Do I need a prescription for Pantoprazole in Japan? ▾
Japan classifies medicines into prescription drugs (医療用医薬品) and OTC drugs (一般用医薬品), the latter further divided into pharmacist-only (第1類) and self-service classes. The Ministry of Health, Labour and Welfare (MHLW) sets the regulatory framework; PMDA reviews safety and efficacy. The exact status of Pantoprazole (Rx or OTC) is determined by PMDA (Pharmaceuticals and Medical Devices Agency); most active ingredients in the Proton pump inhibitor class require prescription, although there are exceptions by country and formulation.
How much does Pantoprazole cost in Japan? ▾
The price in JPY depends on the manufacturer (brand vs authorised generic), the strength and the pack size. Generics are typically substantially cheaper than brands and serve as the economic reference for ongoing use.
Products with Pantoprazole in Japan
Pantoprazole in other countries
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.